Vanda Pharmaceuticals (VNDA)
(Delayed Data from NSDQ)
$4.61 USD
-0.04 (-0.86%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $4.62 +0.01 (0.22%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth A Momentum D VGM
Brokerage Reports
0 items in cart
Vanda Pharmaceuticals Inc. [VNDA]
Reports for Purchase
Showing records 1 - 6 ( 6 total )
Company: Vanda Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Company: Vanda Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
We are terminating coverage of Vanda Pharmaceuticals, Inc. due to the departure from the firm of the covering analyst.
Provider: H.C. Wainwright & Co., Inc.
Company: Vanda Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Vanda Flirts With Renewed Profitability Ahead of Tradipitant Pruritus Data in Q3
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAVIS C
Company: Vanda Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
The Little Engine That Could; Initiate With Buy and $18 Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: DAVIS C
Company: Vanda Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Initial launch of Fanapt positive. Q1 sales of $21 million were $7 million ahead of our view.
Provider: SINGULAR RESEARCH
Analyst: DILORENZO F
Company: Vanda Pharmaceuticals Inc.
Industry: Medical - Biomedical and Genetics
Q4 loss wider than expected due to timing of milestones
Provider: SINGULAR RESEARCH
|